{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T09:58:29Z","timestamp":1772359109308,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.remnie.2025.500229","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:08:12Z","timestamp":1757776092000},"page":"500229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of [18F]FDG PET\/CT in follicular lymphoma"],"prefix":"10.1016","volume":"45","author":[{"given":"A.","family":"D\u00edaz Silv\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cabello Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.F.","family":"Ot\u00f3n S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remnie.2025.500229_bib0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00277-017-3154-z","article-title":"Current prognostic and predictive factors in follicular lymphoma","volume":"97","author":"Sorigue","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.remnie.2025.500229_bib0010","first-page":"202","article-title":"Clinical application of [18F]FDG PET\/CT in follicular lymphoma","volume":"41","author":"D\u00edaz-Silv\u00e1n","year":"2022","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1016\/j.remnie.2025.500229_bib0015","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/S1470-2045(18)30618-1","article-title":"Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial","volume":"19","author":"Trotman","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.remnie.2025.500229_bib0020","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/leu.2014.91","article-title":"How we manage follicular lymphoma","volume":"28","author":"Hiddemann","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.remnie.2025.500229_bib0025","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1200\/JCO.2017.74.1652","article-title":"Long-term results of the FOLL05 trial comparing R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage symptomatic follicular lymphoma","volume":"36","author":"Luminari","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remnie.2025.500229_bib0030","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood-2015-11-624288","article-title":"Follicular lymphoma: evolving therapeutic strategies","volume":"127","author":"Kahl","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.remnie.2025.500229_bib0035","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1200\/JCO.2016.66.9440","article-title":"Baseline metabolic tumor volume predicts outcome in high-tumor-burden follicular lymphoma: a pooled analysis of three multicenter studies","volume":"34","author":"Meignan","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remnie.2025.500229_bib0040","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2011.35.0736","article-title":"Positron emission tomography\u2013computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants","volume":"29","author":"Trotman","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remnie.2025.500229_bib0045","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1200\/JCO.2012.43.0934","article-title":"Impact of [18F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte and GOELAMS","volume":"30","author":"Dupuis","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remnie.2025.500229_bib0050","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the international conference on malignant lymphomas imaging working group","volume":"32","author":"Barrington","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remnie.2025.500229_bib0055","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remnie.2025.500229_bib0060","doi-asserted-by":"crossref","first-page":"6566","DOI":"10.1158\/1078-0432.CCR-13-1511","article-title":"End-therapy positron emission tomography for treatment response assessment in follicular lymphoma: a systematic review and meta-analysis","volume":"19","author":"Pyo","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.remnie.2025.500229_bib0065","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/annonc\/mdt137","article-title":"The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi","volume":"24","author":"Luminari","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.remnie.2025.500229_bib0070","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1080\/10428190701422059","article-title":"Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma","volume":"48","author":"Bishu","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.remnie.2025.500229_bib0075","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s12149-014-0874-1","article-title":"The prognostic value of mid- and post-treatment [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in indolent follicular lymphoma","volume":"28","author":"Lu","year":"2014","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.remnie.2025.500229_bib0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s13139-019-00602-0","article-title":"Predictive value of interim and end-of-therapy 18F-FDG PET\/CT in patients with follicular lymphoma","volume":"53","author":"Boo","year":"2019","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2025.500229_bib0085","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.2147\/CMAR.S216445","article-title":"Prognostic values of baseline, interim and end-of therapy18F-FDG PET\/CT in patients with follicular lymphoma","volume":"11","author":"Zhou","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.remnie.2025.500229_bib0090","author":"Alonso \u00c1lvarez"},{"key":"10.1016\/j.remnie.2025.500229_bib0095","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/annonc\/mdt562","article-title":"The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL)","volume":"25","author":"Luminari","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.remnie.2025.500229_bib0100","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/S2352-3026(14)70008-0","article-title":"Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies","volume":"1","author":"Trotman","year":"2014","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.remnie.2025.500229_bib0105","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/10428194.2016.1196815","article-title":"FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS study","volume":"58","author":"Kostakoglu","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.remnie.2025.500229_bib0110","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/10428194.2016.1213824","article-title":"[18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice","volume":"58","author":"Wong-Sefidan","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.remnie.2025.500229_bib0115","doi-asserted-by":"crossref","first-page":"v83","DOI":"10.1093\/annonc\/mdw400","article-title":"Newly diagnosed and relapsed follicular lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Dreyling","year":"2016","journal-title":"Ann Oncol [Internet]"},{"key":"10.1016\/j.remnie.2025.500229_bib0120","series-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae), B-Cell Lymphomas, Version 1.2020","author":"Zelenetz","year":"2020"},{"key":"10.1016\/j.remnie.2025.500229_bib0125","first-page":"304","article-title":"Optimizaci\u00f3n de los criterios metab\u00f3licos en la valoraci\u00f3n pron\u00f3stica de los pacientes con linfoma. Estudio multic\u00e9ntrico","volume":"36","author":"C\u00f3zar-Santiago M del","year":"2017","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1016\/j.remnie.2025.500229_bib0130","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00259-014-2973-6","article-title":"FDG PET\/CT imaging as a biomarker in lymphoma","volume":"42","author":"Meignan","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2025.500229_bib0135","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2967\/jnumed.119.227249","article-title":"Time to prepare for risk adaptation in lymphoma by standardizing measurement of metabolic tumor burden","volume":"60","author":"Barrington","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remnie.2025.500229_bib0140","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/275805","article-title":"The predictive value of interim and final [18F]fluorodeoxyglucose positron emission tomography after rituximab-chemotherapy in the treatment of non-Hodgkin\u2019s lymphoma: a meta-analysis","volume":"2013","author":"Zhu","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.remnie.2025.500229_bib0145","unstructured":"LITO Developed by C. Nioche Inserm. LIFEx [Internet]. Available from: www.lifexsoft.org."},{"key":"10.1016\/j.remnie.2025.500229_bib0150","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1158\/0008-5472.CAN-18-0125","article-title":"Lifex: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity","volume":"78","author":"Nioche","year":"2018","journal-title":"Cancer Res [Internet]"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925001302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925001302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T09:23:04Z","timestamp":1772356984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808925001302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2253808925001302"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500229","relation":{},"ISSN":["2253-8089"],"issn-type":[{"value":"2253-8089","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of [18F]FDG PET\/CT in follicular lymphoma","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"500229"}}